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gallolyticus bacteremia have concomitant colorectal tumors. This retrospective study was
aimed to identify associations between clinical characteristics and a finding of colorectal
neoplasm in patients with S. bovis bacteremia who had colonoscopy examination. We retro-
spectively reviewed the records of patients with S. bovis bacteremia from Kaohsiung Chang
Gung Memorial Hospital, Kaohsiung, Taiwan, between January 2004 and January 2014. Clinical
data including age, sex, comorbidities, blood culture, and colonoscopy findings were collected
and their relationship to a finding of colorectal cancer was examined. A total of 107 patients
with S. bovis bacteremia were identified, of whom 49 (72% male; age 65  12 years) were
investigated with colonoscopy; 15 of these patients (30.6%) had colorectal adenocarcinoma.
Female sex (pZ 0.014) and a history of noncolorectal malignancy (pZ 0.004) were associated
with a finding of colorectal adenocarcinoma. There were no associations with age, percentage
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Streptococcus bovis and colorectal cancer 197end-stage renal disease. Our results show that S. bovis bacteremia is associated with the pres-
ence of colorectal adenocarcinoma, especially in female patients, and concomitant existence
of other malignancies.
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by-nc-nd/4.0/).Introduction
Group D streptococci, including enterococci and two non-
enterococcal speciesdStreptococcus bovis and Strepto-
coccus equinusdare part of the normal bowel flora of
humans and animals [1]. Klein et al. [2] observed an asso-
ciation between S. bovis bacteremia and colorectal cancer
in the early 1970s. It was also reported that S. bovis
bacteremia was associated with other bowel disorders
including colonic adenomas [3e5]. There are two S. bovis
biotypes (I and II), with biotype I having the ability to
ferment mannitol, a characteristic feature used for differ-
entiating it from biotype II. The prevalence of colorectal
neoplasm in patients infected with S. bovis biotype II is
substantially lower than that observed for biotype I [6]. In
2003, Schlegel et al. [7] proposed a taxonomy that classi-
fied the bacteria into subspecies: Streptococcus gallolyti-
cus subsp. gallolyticus, Streptococcus infantarius subsp.
infantarius, S. infantarius subsp. coli, S. gallolyticus subsp.
pasteurianus, and S. gallolyticus subsp. macedonicus, S.
bovis (previously named S. bovis biotype I). These bacteria
synthesize proteins and polysaccharides to assemble the
capsular sheath, collagen-binding proteins, and three types
of pili, all of which enable them to be highly efficient in
causing bacteremia, endocarditis, and colorectal cancer
[8]. Despite several reports confirming that between 25%
and 80% of patients with S. bovis bacteremia have colo-
rectal cancer [9e11], only limited information is available
as to whether any clinical characteristics of bacteremic
patients are specifically associated with this finding.
Therefore, the aim of our study was to examine the clinical
associations of colorectal adenocarcinoma in patients with
S. bovis bacteremia.Methods
This retrospective chart review study was approved by both
the Institutional Review Board and Ethics Committee of
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung,
Taiwan. The Ethics Committee waived the requirement for
informed consent. All patients had provided written
informed consent before undergoing colonoscopy.
From database records dating between January 2004 and
January 2014, 107 patients with S. bovis bacteremia were
identified, and the following data were extracted: age, sex,
comorbidities [diabetes mellitus, liver cirrhosis, heart dis-
ease, end-stage renal disease (ESRD), malignancy], history
of related infections (meningitis, arthritis, or endocarditis),
percentage of blood cultures that were positive, blood tests
[C-reactive protein, hemoglobin (Hb), hematocrit (Hct),and carcinoembryonic antigen (CEA)], and colonoscopy
findings (polyp size, location, and histopathology). Comor-
bid heart disease was defined as heart failure, valvular
heart disease, or endocarditis. Patients with incomplete
clinical data or an incomplete colonoscopic examination
were excluded.
All S. bovis isolates were identified by Gram stain as
Gram-positive lactic acid bacteria growing as pairs or
chains of cocci, and subsequent analysis with matrix-
assisted laser desorption/ionization time-of-flight mass
spectrometry in the Microbiology Laboratory of Kaohsiung
Chang Gung Memorial Hospital. The number of blood cul-
tures yielding S. bovis for each patient was expressed as a
percentage of the total number of cultures analyzed.
Colonoscopies were performed using an Olympus CF Q260
or H260 video colonoscope (Olympus Optical Co., Ltd,
Tokyo, Japan), with recording of all videos for subsequent
review. The diagnosis of colorectal adenocarcinoma
including carcinoma in situ was confirmed by the histo-
pathological examination of either colonoscopic biopsy
specimens or the resected specimen. Additional colorectal
neoplasms were defined as tubular adenoma, villous ade-
noma, tubulovillous adenoma, and serrated adenoma after
histopathological examination.
Statistical analyses
All data were collected and analyzed using Microsoft Excel
2003 (Microsoft Corporation, Redmond, WA, USA) and IBM
SPSS statistics version 22 (IBM, Armonk, NY, USA). We
divided the patients into the following two groups: (1) S.
bovis bacteremia without colon cancer and (2) S. bovis
bacteremia with colon cancer, according to the histopath-
ological diagnosis of colorectal adenocarcinoma, and
examined differences in proportions for each variable using
Chi-square test, with p < 0.05 taken to indicate statistical
significance. Univariate and multivariate logistic regression
analyses were performed to examine relationships between
the clinical characteristics and the finding of colorectal
adenocarcinoma. Data are reported as mean  standard
deviation.Results
In this study, 107 patients with S. bovis bacteremia were
identified, among which 14 patients (28.6%) were female.
The mean age of the study patients was 65  12 years.
Among the 107 patients with S. bovis bacteremia, 28
(26.2%) concomitantly had cirrhosis, 10 (9.3%) had gall-
stones, 11 (10.2%) had acute cholecystitis, two (1.9%) had
Table 1 Univariate analysis for categorical variables
associated with a finding of colorectal cancer in patients
with Streptococcus bovis bacteremia.
Factor Streptococcus bovis
bacteremia without
colon cancer
Streptococcus
bovis bacteremia
with colon cancer
p
Sex 0.041*
Female 7 (20.6) 7 (46.7)
Male 27 (79.4) 8 (53.3)
Other malignancies 0.014*
No 24 (70.6) 5 (33.3)
Yes 10 (29.4) 10 (66.7)
Liver cirrhosis 0.083
No 20 (58.8) 13 (86.7)
Yes 14 (41.2) 2 (13.3)
Diabetes 0.604
No 23 (67.6) 9 (60.0)
Yes 11 (32.4) 6 (40.0)
Heart disease 0.148
No 6 (17.6) 6 (40.0)
Yes 28 (82.4) 9 (60.0)
End-stage renal disease 0.336
No 22 (64.7) 12 (80.0)
Yes 12 (35.3) 3 (20.0)
Arthritis >0.99
No 33 (97.1) 15 (100)
Yes 1 (2.9) 0 (0)
All data are presented as n (%).
* Mean significant difference.
Table 2 Univariate analysis for continuous variables
associated with a finding of colorectal cancer in patients
with Streptococcus bovis bacteremia.
Factor Streptococcus
bovis
bacteremia
without colon
cancer
Streptococcus
bovis
bacteremia
with colon
cancer
p
Age (y) 68.7  13.9 68.9  9.1 0.954
Positive blood
cultures (%)
79.35  29.5 65.9  35.3 0.183
C-reactive
protein (mg/L)
83.9  82.2 142.4  120.6 0.252
Hemoglobin
(g/dL)
10.5  2.3 10.9  2.7 0.610
Hematocrit (%) 31.8  6.5 31.9  7.1 0.933
Carcinoembryonic
antigen
(ng/mL)
27.6  88.9 423.7  1190.2 0.274
All data are presented as mean  standard deviation.
198 C.-E. Tsai et al.acute pancreatitis, and 16 (15.0%) had esophageal varices.
Twenty-four patients (22.4%) had peptic ulcer disease.
Of the 107 patients, 49 had a record of complete clinical
data and colonoscopy. Among these 49 patients, 15 (30.7%)
were found to have a colorectal adenocarcinoma. Full
colonoscopic examination was not performed due to the
following reasons: inadequate bowel preparation, patient
refusal to the examination, unstable hemodynamic status,
and/or critical condition, which was not appropriate to the
procedure. Among the 49 patients who received colonos-
copy, 35 (71.4%) patients had a total of 36 colorectal neo-
plasms [tubular adenoma: 15 (41.2%); tubulovillous
adenoma: 6 (16.7%); villous adenoma: 0 (0%); adenocarci-
noma: 15 (41.2%)] and six hyperplastic polyps.
In the noncolorectal adenocarcinoma group (n Z 34),
there was male predominance (27/34; 79.4%) with a mean
age of 68.7  13.9 years. Documented comorbidities in this
group included 10 (29.4%) cases with other malignancies, 14
(41.2%) with liver cirrhosis, 11 (32.4%) with diabetes mel-
litus, 28 (82.4%) with heart disease, 12 (35.2%) with ESRD,
and one (2.9%) with arthritis. The colonoscopy findings
were as follows: 17 patients had one polyp, two patients
had two polyps, and one patient had three polyps. A total of
15 (44.1%) patients had at least one polyp equal to or larger
than 1 cm; in five patients (11.7%), the polyps were < 1 cm
and 14 patients did not have a polyp.
In the colorectal adenocarcinoma group (n Z 15), there
was only a slight male predominance (8/15; 53.5%) and the
mean age was 68.9  9.1 years. Documented comorbidities
in this group included 10 (66.7%) cases with other malig-
nancy, two (13.3%) cases with liver cirrhosis, six (40.0%)
cases with diabetes mellitus, nine (60.0%) cases with heart
disease, three (20.0%) cases with ESRD, and none with
arthritis; 12 patients had only one neoplasm and three
patients had two neoplasms. The mean size of the tumor
was 4.2  3.8 cm, with the majority located at the rectum
(1 at cecum/2 at ascending colon/1 at transverse colon/1
at descending colon/2 at sigmoid colon/8 at rectum) and
staged as Stage II [3 intraepithelial carcinomas, 6 Stage II (4
Stage IIa and 2 Stage IIb), 2 Stage IIIb, and 4 Stage IV] with
moderate differentiation (1 well differentiated/8 moder-
ately differentiated/6 unknown).
The timing in the diagnosis of extracolonicmalignancywas
as follows: six of the 10 extracolonic cancers were diagnosed
before S. bovis bacteremia, with amean period of 18months.
The remaining four extracolonic cancers were, however,
diagnosed only after S. bovis bacteremia, with amean period
of 6 months. Among the 10 extracolonic cancers, there were
four hepatocellular carcinomas (2 Stage II, 1 Stage IIIc, and 1
Stage IV), two bladder cancers (1 Stage 0 and 1 Stage I
papillary urothelial carcinoma), two renal cell carcinomas (1
Stage 0 squamous cell carcinoma and 1 Stage II clear cell
carcinoma), one buccal cancer (Stage I squamous cell carci-
noma), and one lung cancer (Stage IV small cell lung cancer).
Univariate analysis of categorical variables showed that
sex (p Z 0.041) and a history of other malignancies
(p Z 0.014) were significantly related to colon adenocarci-
noma. The proportion of male patients in the colon cancer
group (53.3%) was less than that in the noncancer group
(79.4%). Ten of the 15 patients (66.7%) with colorectal
cancer were found to have a history of other malignancies
compared with only 10 of 34 patients (29.4%) in thenoncolorectal cancer group. Comorbidity with liver
cirrhosis, diabetes mellitus, heart disease, ESRD, and
arthritis showed no relationship with colon adenocarcinoma
in the univariate analysis (Table 1) nor were there any sig-
nificant relationships with age, percentage of blood cultures
that were positive, C-reactive protein, Hb, Hct, or CEA
(Table 2).
Table 3 Binary logistic regression of predictors of colo-
rectal cancer in patients with Streptococcus bovis
bacteremia.
Factor Comparison OR (95% CI) p
Sex Male vs.
female
0.101 (0.016e0.629) 0.014 *
Other
malignancy
Yes vs. no 12.376 (2.207e69.402) 0.004 *
Endocarditis Yes vs. no 0.236
CI Z confidence interval; OR Z odds ratio.
* Mean significant difference.
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predictors of colon adenocarcinoma, which revealed that
female sex (p Z 0.014) and comorbidity with other malig-
nancies (p Z 0.004) were significantly associated with
colorectal cancer. There was no correlation with age,
percentage of blood cultures that were positive, liver
cirrhosis, diabetes mellitus, heart disease (including endo-
carditis), ESRD, arthritis, or other blood tests (Table 3).Discussion
Bacteremia involving S. bovis, an organism usually found in
the healthy gut, is known to be associated with colorectal
neoplasia. One meta-analysis indicated a sevenfold in-
crease in the risk of having a colorectal neoplasm in the
presence of S. bovis septicemia [12]. Other studies have
shown that up to 80% of patients with bacteremia caused by
S. bovis biotype I (now called S. gallolyticus subsp. gallo-
lyticus) have a colorectal neoplasm, a rate markedly
greater than that noted in the general population [13,14].
By contrast, the prevalence of colorectal neoplasm in pa-
tients infected with S. bovis biotype II is significantly lower
than the rate in patients infected with biotype I, and does
not appear to be higher than the general population [6].
However, identification of S. bovis subtypes is not widely
available, and is not a routine practice in our hospital. The
growth of S. bovis in stool aspiration content or the exis-
tence of bacterial-specific antibody provides an alternative
way to identify patients at increased risk of having colo-
rectal neoplasia [15e17]. However, a few published reports
have examined the clinical characteristics specifically
associated with colorectal adenocarcinoma in patients with
S. bovis bacteremia.
A recent meta-analysis of 20 published case series
showed that 43% of patients with S. bovis bacteremia that
was examined by colonoscopy had adenomas and 18% had
carcinomas [14]. Our finding of colorectal neoplasm (ade-
noma and/or carcinoma) in 61.2% of patients and adeno-
carcinoma in 30.7% of patients accords very closely with
these figures. In addition, we observed that female sex and
comorbidity with noncolorectal malignancy were particu-
larly associated with colorectal adenocarcinoma.
It is unclear why female sex should be a risk factor. It is
established that the age-adjusted incidence of colonic ad-
enomas and adenocarcinoma is higher in men than in
women, possibly explained by the indirect tumor-promoting
effects of testosterone [18]. Most caseecontrol studiesexamining the association of S. bovis bacteremia with
colorectal disease enrolled patients who were matched by
sex and age [5,13], so the relationship we observed has not
been apparent in the past.
Several studies have reported a link between S. bovis
bacteremia and extracolonic malignancy. Previous re-
searchers observed that 29% of such patients harbored tu-
mors in the duodenum, gallbladder, pancreas, ovary,
uterus, lung, or hematopoietic system [19,20], and some
investigators have advocated more thorough investigation
of the gastrointestinal tract than with colonoscopy alone
[21,22]. In a Taiwanese study [23], 40% of S. bovis bacter-
emic patients had underlying malignancies, 21% had liver
cirrhosis, and 24% had diabetes mellitus. A recent large
prospective study spanning 20 years observed 22 cases of
noncolorectal cancer among 133 bacteremic patients (17%)
[24]. The malignancies observed in these studies included
esophageal [21] and gastric carcinoma [3,25], gastric lym-
phoma, and pancreatic carcinoma.
It remains controversial as to whether S. bovis plays an
etiological role in the development of colorectal tumors or
is a consequence of the disease. Three mechanisms have
been proposed. First, it has been suggested that a chronic
inflammatory response to S. bovis could play a role in the
malignant transformation of colonic mucosa. Antigens
extracted from the cell wall of S. bovis are associated with
overexpression of cyclooxygenase-2 and increased con-
centrations of interleukin-8 in vitro. These are frequently
overexpressed in human colorectal cancers and can inhibit
apoptosis, and stimulate proliferation and angiogenesis
[26]. Second, S. bovis has a strong capacitydpartly due to
specific collagen- and heparan sulfate-binding proteins and
pilidto form biofilms on collagen-rich surfaces, which
in vivo are found on damaged heart valves as well as on
precancerous sites with a displaced epithelium [27,28].
Third, S. bovis has the ability to increase vascular perme-
ability and facilitate bacterial translocation into the portal
circulation [29]. Moreover, the bacteria can then bypass the
hepatic reticuloendothelial system and access the systemic
circulation easily [30].
Our study has several limitations. First, it was conducted
in a single center with a relatively small number of patients.
Our analysis indicates that it would be worthwhile to collect
further data from multiple centers to identify additional
associations. Second, not all the patients with S. bovis
bacteremia were examined with colonoscopy although the
importance of colonoscopy screening in these patients had
been emphasized in the previous studies. In conclusion, this
study suggests that S. bovis bacteremia is associated with
colorectal adenocarcinoma, especially in female patients,
and concomitant existence of other malignancies.
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